Cardiology

Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey.

Related Articles

Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey.

Eur Heart J. 2019 May 23;:

Authors: Packer M

PMID: 31121027 [PubMed – as supplied by publisher]

Source link




Related posts

Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women

Newsemia

Letter by Guo et al Regarding Article, “Prevalence and Natural History of Superficial Siderosis: A Population-Based Study” [Letter to the Editor]

Newsemia

How many calories are there in different cuts of chicken?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy